Dr. Mamta Manglani

• MD (Pediatrics)
• DCH
• FRCPCH (UK)

• Former Director, MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & Bone Marrow Transplantation Centre, Borivali (East), Mumbai
• Former Professor & Head, Department of Pediatrics, Lokmanya Tilak Municipal Medical College & General Hospital (LTMMC & LTMGH), Sion, Mumbai.
• Chief, Division of Pediatric Hematology-Oncology & Program Director, Pediatric Centre of Excellence for HIV Care, Lokmanya Tilak Municipal Medical College & General Hospital (Sion Hospital), Mumbai.

Dr. Manglani has authored and co-authored numerous national and international research papers, book chapters, and clinical studies on childhood cancers, thalassemia, bone marrow transplantation, and pediatric HIV.

1. Case Report - Acquired Pure Red Cell Aplasia in a Child
2. Klebsiella Pneumoniae Osteo- myelitis in Sickle Cell Anemia
3. Antenatal supplementation--effect on iron status of infants
4. Evaluation of naked eye single tube osmotic fragility test in detecting beta-thalassemia trait
5. Askin Rosai tumor.
6. Klebsiella pneumoniae osteomyelitis in sickle cell anemia
7. Successful treatment with cyclophosphamide in a large hepatic hemangioendothelioma
8. Current role of intravenous gammaglobulin
9. NESTROFT'--an effective screening test for beta thalassemia trait
10. Intussusception in an Infant With Acute Lymphoblastic Leukemia
11. Anemia in Newborn
12. Congenital Erythrocytosis With Elevated Erythropoietin Level
13. Intussusception in an infant with acute lymphoblastic leukemia: A case report and review of the literature
14. Leukemic transformation in Fanconi's anemia
15. Congenital factor V deficiency - A case report
16. Toxicity study of pegaspargase
17. Clinical spectrum of HIV infection
18. Acquired pure red cell aplasia in a child
19. Chapter-09 Bone Marrow Failure Syndromes in the Neonate
20. Diamond-Blackfan Anemia: Report of 6 Cases
21. Prevention of mother to child transmission of HIV
22. Griscelli syndrome: A case report
23. Effect of deferiprone on urinary zinc excretion in multiply transfused children with thalassemia major
24. Rational use of blood components - An audit
25. Pseudomonas diarrhea in a child suffering from acute lymphatic leukemia
26. All Trans Retinoic Acid (ATRA) induced myositis
27. Isolation of Streptobacillus moniliformis from the blood of a child with acute lymphoblastic leukaemia
28. Assessment of safety and immunogenicity of two different lots of diphtheria,tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process
29. Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process
30. Hidradenitis suppurativa in a HIV-infected child
31. Correspondence
32. Acute glomerulonephritis in dengue haemorrhagic fever in the absence of shock, sepsis, haemolysis or rhabdomyolysis
33. Deferiprone is Superior to Deferasirox and Desferrioxamine in Cardiac Iron Overload.
34. Antiretroviral Therapy in Children: Recent Advances
35. Hematological Manifestations in Parvovirus Infection
36. Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
37. Multicenter prospective surveillance of invasive pnuemococcal disease in children (<5 years) from Maharashtra, India.
38. Guidelines for screening, diagnosis and management of Hemoglobinopathies
39. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-DT): A Multicenter, Open-label, Non-randomized, Phase III Clinical Trial
40. Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India
41. Immunoglobulin levels and CD4 / CD8 counts in β — Thalassemia major
42. Chapter-05 Blood Dyscrasias and Anesthesia in Children
43. Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: Identification of 9 novel mutations
44. Human Vaccines & Immunotherapeutics A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine
45. 21645515.2015
46. A comparative clinical study to assess safety and reactogenicity of a DTPw-HepB+Hib vaccine (vol 11, pg 901, 2015)
47. Source of factor VIII replacement (PLASMATIC OR RECOMBINANT) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the multicenter randomized sippet study
48. Prevalence of pulmonary hypertension in children with sickle cell disease
49. Chapter-17 Thalassemia Syndromes
50. Chapter-11 Bleeding Neonate: Approach and Management
51. Isolated conjunctival mass presenting as acute myeloid leukemia in an infant
52. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
53. Building Developmental-Behavioral Pediatrics in Low-Middle Income Countries Through International Collaboration
54. Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families
55. To study the factors affecting quality of life in children suffering from hemophilia
56. Is serum ferritin a reliable marker for evaluation of cardiac and hepatic iron overload in patients with β-thalassemia major?
57. To study the factors affecting quality of life in children suffering from hemophilia
58. Hematopoietic stem cell transplantation in a public hospital – Our experience
59. Chapter-058 Approach to a Child with Persistent Anemia
60. A study of the adverse drug reactions of L-asparaginase in newly diagnosed children with acute lymphoblastic leukemia
61. Autoimmune complication post HSCT in a case of MDS with monosomy 7
62. Palliative care and Pediatric HIV
63. Prospective Study of Impact of Feeding Practices on the Growth, Development and Infections in HIV Exposed Infants versus HIV non-exposed Infants.
64. Prospective Study of Impact of Feeding Practices on the Growth, Development and Infections in HIV Exposed Infants versus HIV non-exposed Infants.
65. Acquired methemoglobinemia–A sporadic Holi disaster
66. A study of clinical spectrum of opportunistic infections in HIV infected children and its correlation with CD4 count and anti-retroviral therapy
67. Adherence to antiretroviral therapy and factors affecting adherence among paediatric HIV patients
68. Management of ß-thalassemia – Consensus and controversies!
69. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
70. A Rare Immunodeficiency Disorder Masquerading As Auto-Immune Hemolytic Anemia
71. The Genes Speak - A Rare Case of Hemolytic Anemia!
72. Common Mutations of β-Thalassemia – A Changing Arena!
73. Counselling in Thalassemia – Encompassing Comprehensive Care!
74. Familial Hemophagocytic Lymphohistiocytosis (Fhl) – A Case Series
75. Thalassemia: Impact of Physiotherapy
76. Pediatric Cml, A Rare Entity With Diagnostic And Therapeutic Challenges: Case Reports
77. Out-of-pocket expenditure incurred by families of children newly diagnosed with cancer in India prior to start of treatment – First report of a multi-site prospective study
78. Families of Children Newly Diagnosed With Cancer Incur Significant Out-of-Pocket Expenditure for Treatment: Report of a Multi-Site Prospective Longitudinal Study From India (INPOG-ACC-16-01)
79. Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study
80. Pancytopenia In Infancy – A Reflection Of Defective Gene (Mysm1 Deficiency: An Orphan Entity)
81. To Study Renal Dysfunction In Children And Adolescents With Thalassemia Major
82. Aplastic Anaemia- Delving Into The Genes
83. Peripheral Smear Examination: More Than Window Into The Hematopoietic System
84. To Study Renal Dysfunction In Children And Adolescents With Thalassemia Major
85. Hearing loss with oral chelators in thalassemia
86. Molecular genotyping of clinically important blood group antigens in patients with thalassaemia
87. Red cell adenylate kinase deficiency in India: Identification of two novel missense mutations (c.71A>G and c.413G>A)
88. Impact of Anemia on Outcome of HIV-Infected Pediatric Patients: A Prospective Observational Study
89. Indigenously Prepared Ready-to-use Therapeutic Food (RUTF) in Children with Severe Acute Malnutrition
90. Can telemedicine initiative be an effective intervention strategy for improving treatment compliance for pediatric HIV patients: Evidences on costs and improvement in treatment compliance from Maharashtra, India
91. Guidance for Pediatric Hematology-Oncology (PHO) and Hematopoietic Stem Cell Transplant Services during COVID-19 Pandemic: A Consensus Statement by PHO Chapter of Indian Academy of Pediatrics
92. Upfront use of plerixafor and G-CSF with large-volume (LVL) apheresis in pediatric autologous stem cell transplants
93. To study outcome of patients previously exposed to steroids with treatment naïve in paediatric acute lymphoblastic leukemia (ALL) in a tertiary care centre
94. Mercaptopurine (6-MP) induced symptomatic hypoglycemia: A rare side effect!
95. Prevalence of TPMT/ MTHFR/ RFC/NUDT15 gene polymorphisms and effect on 6-mercaptopurine & methotrexate dosage in Indian children with acute lymphoblastic leukemia
96. Pediatric MDS: More than meets the eye
97. A study of anti-oxidant levels pre and post induction chemotherapy in children with acute lymphoblastic leukemia
98. Current scenario of pediatric brain tumors in a developing country: A single center study
99. A clinical profile of early T cell precursor all in a tertiary care centre
100. Vanishing catheter – Fracture at exit with migration of entire PICC!
101. Neurotoxicity with vinca alkaloids- A retrospective observational study at a tertiary care center
102. Reaching the Unreached: Providing Quality Care to HIV-Infected Children through Telemedicine—An Innovative Pilot Initiative from Maharashtra, India
103. IntJPed
104. Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India
105. Assessing the Effectiveness of a Telemedicine Initiative in Clinical Management of Children Living with HIV/AIDS in Maharashtra, India
106. Vitamin C Deficiency and Oxidant Levels in Children With Transfusion-Dependent β-Thalassemia
107. Pediatric Blood & Cancer Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trial
108. Comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects
109. Hematopoietic stem cell transplant (HSCT) in transfusion dependent thalassemia – Experience of a public sector hospital in Mumbai
110. Haploidentical stem cell transplantation of paediatric hematolymphoid conditions - An experience from a public sector hospital
111. Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India
112. Attitudes and acceptability of children, caregivers, and healthcare providers about using telemedicine for pediatric HIV care in a resource-limited setting
113. TO STUDY RENAL DYSFUNCTION IN CHILDREN AND ADOLESCENTS WITH THALASSEMIA MAJOR
114. Diagnosis, Treatment and Prevention of Nutritional Anemia in Children: Recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics
115. PROGNOSTIC VARIABLES AND OUTCOME OF HIGH-RISK NEUROBLASTOMA TREATED IN A TERTIARY CANCER CENTRE IN INDIA.
116. Prenatal diagnosis of thalassemia: A cost-effective step towards eradication
117. Autologous hematopoietic stem cell transplant in pediatric lymphoma our experience
118. Fluconazole as primary antifungal prophylaxis for pediatric hematopoietic stem cell transplant in antifungal NA ÆVE patients
119. Inherited thrombocytopenias: Early diagnosis for optimum treatment
120. Matched unrelated donor hematopoietic stem cell transplant in a child with chronic myeloid leukemia
121. Sirolimus as immunosuppressive agent in pediatric allogenic hematopoetic transplant recipients
122. Therapeutic outcomes of severe aplastic anemia: The earlier the better!
123. Spectrum of patients with hemoglobin E-B thalassemia and their response to hydroxyurea - Experience of a single centre
124. Allogenic HSCT in primary immunodeficiency disorder: A hope to cure
125. Sclerotic GVHD: an uncommon complication in children post HSCT - A case report
126. Survey to assess the quality of services available for thalassemia diagnosis and management in India
127. Ruxolitinib- A hope for steroid refractory chronic GVHD manifesting as nephrotic syndrome
128. Maternal-Fetal Iron Kinetics
129. PB2431: OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA IN PEDIATRIC POPULATION - A SINGLE CENTER EXPERIENCE FROM PUBLIC HOSPITAL
130. Efficacy of Low Dose Vs Standard Dose of Thalidomide in Patients with Transfusion-Dependent Thalassemia (TDT): A Non-Inferiority Trial
131. Real-world outcomes of children treated for high-risk neuroblastoma and the challenge in identifying the ultra-high-risk
132. Impact of high-risk factors on the outcomes of HSCT in children with acquired severe aplastic anaemia
133. Thrombotic Microangiopathy in children: Redefining HUS, TTP and related disorders!
134. The Indian Academy of Pediatrics and Directorate General of Health Services, Government of India White Paper on Transition of Care for Youth with Special Health Care Needs
135. Association of TGF-β1 -509 C > T (rs1800469) polymorphism with bone marrow failure severity in Fanconi anemia subjects